- Home
- ENTX vs NTRB Comparison
ENTX vs NTRB Comparison
Compare ENTX & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENTX | NTRB |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | Israel | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9M | 44.2M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENTX | NTRB |
|---|---|---|
| Price | $1.19 | $3.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 187.3K | 10.9K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $42,000.00 | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $4.76 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $3.42 |
| 52 Week High | $3.22 | $11.68 |
Technical Indicators
Market Signals| Indicator | ENTX | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 46.39 | 47.37 |
| Support Level | $0.96 | $3.51 |
| Resistance Level | $1.61 | $4.50 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 46.15 | 59.24 |
Price Performance
Historical ComparisonAbout ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.